Henry Schein, Inc. (NASDAQ:HSIC) Shares Bought by Two Sigma Investments LP

Two Sigma Investments LP lifted its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 216.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 30,709 shares of the company's stock after acquiring an additional 21,009 shares during the quarter. Two Sigma Investments LP's holdings in Henry Schein were worth $2,125,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also modified their holdings of HSIC. Venturi Wealth Management LLC increased its position in shares of Henry Schein by 3,347.1% during the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock worth $41,000 after acquiring an additional 569 shares during the period. Quent Capital LLC increased its holdings in Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company's stock valued at $47,000 after buying an additional 323 shares during the last quarter. Smartleaf Asset Management LLC increased its holdings in Henry Schein by 23.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock valued at $52,000 after buying an additional 143 shares during the last quarter. Allworth Financial LP increased its holdings in Henry Schein by 180.7% in the fourth quarter. Allworth Financial LP now owns 946 shares of the company's stock valued at $71,000 after buying an additional 609 shares during the last quarter. Finally, Canada Post Corp Registered Pension Plan purchased a new position in Henry Schein in the fourth quarter valued at $95,000. Hedge funds and other institutional investors own 96.62% of the company's stock.

Insider Activity at Henry Schein

In related news, Director Philip A. Laskawy sold 2,604 shares of the firm's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares in the company, valued at $1,762,147.20. This trade represents a 9.50% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Bradford C. Connett sold 4,036 shares of the firm's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares of the company's stock, valued at approximately $4,460,251.20. The trade was a 6.05% decrease in their position. The disclosure for this sale can be found here. 1.08% of the stock is owned by insiders.

Henry Schein Stock Performance

Shares of HSIC traded up $0.08 during mid-day trading on Thursday, hitting $70.47. 865,137 shares of the company's stock were exchanged, compared to its average volume of 1,684,179. Henry Schein, Inc. has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The firm has a market capitalization of $8.58 billion, a P/E ratio of 29.00, a P/E/G ratio of 2.13 and a beta of 0.87. The business's 50 day moving average is $67.75 and its two-hundred day moving average is $71.66. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter in the prior year, the firm earned $1.10 earnings per share. The business's quarterly revenue was down .1% compared to the same quarter last year. On average, equities analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Wall Street Analyst Weigh In

HSIC has been the topic of several recent analyst reports. Wall Street Zen lowered Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Barrington Research dropped their price objective on Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a report on Tuesday, May 6th. Piper Sandler dropped their price objective on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a report on Wednesday, April 30th. Wells Fargo & Company dropped their price objective on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Finally, UBS Group dropped their price objective on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a report on Wednesday, February 26th. Six investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $79.30.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.